FIDVAXI

Serial Number 79352782
Registration 7220670
700

Registration Progress

Application Filed
Sep 1, 2022
Under Examination
Approved for Publication
Sep 5, 2023
Published for Opposition
Sep 5, 2023
Registered
Nov 21, 2023

Trademark Image

FIDVAXI

Basic Information

Serial Number
79352782
Registration Number
7220670
Filing Date
September 1, 2022
Registration Date
November 21, 2023
Published for Opposition
September 5, 2023
Drawing Code
5

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 21, 2023
Registration
Registered
Classes
042

Rights Holder

Genexine, Inc.

03
Address
172, Magokjungang-ro, Gangseo-gu Seoul
(Magokdong, Bio Innovation Park),
KR

Ownership History

Genexine, Inc.

Original Applicant
03
KR

Genexine, Inc.

Owner at Publication
03
KR

Genexine, Inc.

Original Registrant
03
KR

Legal Representation

Attorney
Leigh Ann Lindquist

USPTO Deadlines

Next Deadline
1574 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-11-21)
Due Date
November 21, 2029
Grace Period Ends
May 21, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

32 events
Date Code Type Description Documents
Feb 7, 2025 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Mar 18, 2024 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Feb 27, 2024 FIMP P FINAL DISPOSITION PROCESSED Loading...
Feb 27, 2024 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Feb 21, 2024 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Nov 21, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 21, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Sep 5, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 5, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 4, 2023 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Aug 16, 2023 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Aug 16, 2023 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Aug 16, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 28, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 6, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 6, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 6, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 13, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 13, 2023 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Loading...
Jun 13, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jun 13, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jun 13, 2023 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jun 13, 2023 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Feb 8, 2023 RFNT P REFUSAL PROCESSED BY IB Loading...
Jan 13, 2023 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Jan 13, 2023 RFRR P REFUSAL PROCESSED BY MPU Loading...
Nov 3, 2022 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Nov 2, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 2, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 25, 2022 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Oct 21, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 20, 2022 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 042
Research and development of vaccines and medicines; development of new cell therapy products for others; drug discovery services; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; Pharmaceutical drug development services; inspection of pharmaceuticals; development of pharmaceutical preparations and medicines; laboratory research in the field of pharmaceuticals; consultancy relating to pharmaceutical research and development; pharmaceutical research and development; research on the subject of pharmaceuticals; clinical research in the field of medicine; consultancy pertaining to pharmacology; medical laboratories; medical research laboratory services; medical research laboratory services for predicting disease; medicine research; testing of pharmaceuticals

Classification

International Classes
042